Interferon-ε as potential inhibitor of Chlamydia trachomatis infection.

Anti-bacterial activity Chlamydia trachomatis Genital infections Interferon-ε

Journal

Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 11 09 2023
revised: 24 10 2023
accepted: 25 10 2023
medline: 6 12 2023
pubmed: 28 10 2023
entrez: 27 10 2023
Statut: ppublish

Résumé

Chlamydia trachomatis, the main cause of bacterial sexually transmitted diseases, is responsible for severe reproductive sequelae. Amongst all the cytokines involved in host immunity towards this pathogen, IFN-ε has recently acquired importance for its potential contribution to the female reproductive tract innate defenses. Herein, our study aimed to explore, for the first time, the activity of IFN-ε toward C. trachomatis in an in vitro infection model, by testing its effects on the different phases of chlamydial developmental cycle, as well as on the ultrastructural characteristics of chlamydial inclusions, via transmission electron microscopy. Main result is the capability of IFN-ε to alter C. trachomatis growth, as suggested by reduced infectious progenies, as well as a patchy distribution of bacteria and altered morphology of reticulate bodies within inclusions. In conclusion, our results suggest that IFN-ε could play a role in the innate and adaptive immune defenses against C. trachomatis; in the future, it will be needed to investigate its activity on an infection model more closely resembling the physiological environment of the female genital tract.

Identifiants

pubmed: 37890679
pii: S0882-4010(23)00460-6
doi: 10.1016/j.micpath.2023.106427
pii:
doi:

Substances chimiques

Cytokines 0
Interferons 9008-11-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106427

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Rosa Sessa reports article publishing charges was provided by University of Rome "Sapienza". If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Simone Filardo (S)

Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University, P.le Aldo Moro, 5, 00185, Rome, Italy. Electronic address: simone.filardo@uniroma1.it.

Marisa Di Pietro (M)

Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University, P.le Aldo Moro, 5, 00185, Rome, Italy. Electronic address: marisa.dipietro@uniroma1.it.

Giuseppina Bozzuto (G)

National Centre for Drug Research and Evaluation, Italian National Institute of Health, Viale Regina Elena, 299, 00161, Rome, Italy. Electronic address: giuseppina.bozzuto@iss.it.

Matteo Fracella (M)

Department of Molecular Medicine, Laboratory of Virology, Sapienza University, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Viale di Porta Tiburtina, 28, 00185, Rome, Italy. Electronic address: matteo.fracella@uniroma1.it.

Camilla Bitossi (C)

Department of Molecular Medicine, Laboratory of Virology, Sapienza University, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Viale di Porta Tiburtina, 28, 00185, Rome, Italy. Electronic address: camilla.bitossi@uniroma1.it.

Agnese Molinari (A)

National Centre for Drug Research and Evaluation, Italian National Institute of Health, Viale Regina Elena, 299, 00161, Rome, Italy. Electronic address: agnese.molinari@iss.it.

Carolina Scagnolari (C)

Department of Molecular Medicine, Laboratory of Virology, Sapienza University, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Viale di Porta Tiburtina, 28, 00185, Rome, Italy. Electronic address: carolina.scagnolari@uniroma1.it.

Guido Antonelli (G)

Department of Molecular Medicine, Laboratory of Virology, Sapienza University, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, Viale di Porta Tiburtina, 28, 00185, Rome, Italy. Electronic address: guido.antonelli@uniroma1.it.

Rosa Sessa (R)

Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University, P.le Aldo Moro, 5, 00185, Rome, Italy. Electronic address: rosa.sessa@uniroma1.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH